TAK-632   Click here for help

GtoPdb Ligand ID: 10387

Synonyms: compound 8B [PMID: 23906342] | TAK632
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: TAK-632 is a pan-RAF kinase inhibitor [2]. It binds human BRAF in the DFG-out conformation. TAK-632 inhibits RIPK1/3-induced necrosome formation and necroptosis, and this action was shown to be mediated by direct ligand interaction with RIPK1 and RIPK3 (and inhibition of their kinase activities) [1,3].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 132.35
Molecular weight 554.1
XLogP 4.46
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES N#Cc1c(ccc2c1sc(n2)NC(=O)C1CC1)Oc1ccc(c(c1)NC(=O)Cc1cccc(c1)C(F)(F)F)F
Isomeric SMILES N#Cc1c(ccc2c1sc(n2)NC(=O)C1CC1)Oc1ccc(c(c1)NC(=O)Cc1cccc(c1)C(F)(F)F)F
InChI InChI=1S/C27H18F4N4O3S/c28-19-7-6-17(12-21(19)33-23(36)11-14-2-1-3-16(10-14)27(29,30)31)38-22-9-8-20-24(18(22)13-32)39-26(34-20)35-25(37)15-4-5-15/h1-3,6-10,12,15H,4-5,11H2,(H,33,36)(H,34,35,37)
InChI Key OJFKUJDRGJSAQB-UHFFFAOYSA-N
Bioactivity Comments
TAK-632 ihas demonstrated anti-tumour activity in vitro and in xenograft models carrying BRAF and NRAS mutant tumours [2]
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Raf-1 proto-oncogene, serine/threonine kinase Hs Inhibitor Inhibition 9.3 pKd - 2
⤷ pKd 9.3 (Kd 5.2x10-10 M) [2]
Description: Dissociation constant determined by Surface Plasmon Resonance.
B-Raf proto-oncogene, serine/threonine kinase Hs Inhibitor Inhibition 8.8 pKd - 2
⤷ pKd 8.8 (Kd 1.6x10-9 M) [2]
Description: Dissociation constant determined using Surface Plasmon Resonance.
receptor interacting serine/threonine kinase 3 Hs Inhibitor Inhibition 7.0 pKd - 1
⤷ pKd 7.0 (Kd 1.05x10-7 M) [1]
Description: Binding constant determined by KINOMEscan assay.
receptor interacting serine/threonine kinase 1 Hs Inhibitor Inhibition 6.3 pKd - 1
⤷ pKd 6.3 (Kd 4.8x10-7 M) [1]
Description: Binding constant determined by KINOMEscan assay.
Raf-1 proto-oncogene, serine/threonine kinase Hs Inhibitor Inhibition 8.9 pIC50 - 2
⤷ pIC50 8.9 (IC50 1.4x10-9 M) [2]
Description: Biochemical enzyme inhibition assay.
B-Raf proto-oncogene, serine/threonine kinase Hs Inhibitor Inhibition 8.1 pIC50 - 2
⤷ pIC50 8.1 (IC50 8.3x10-9 M) [2]
Description: Biochemical enzyme inhibition assay.
aurora kinase B Hs Inhibitor Inhibition 7.2 pIC50 - 2
⤷ pIC50 7.2 (IC50 6.6x10-8 M) [2]
Description: Biochemical enzyme inhibition assay.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
platelet derived growth factor receptor beta Hs Inhibitor Inhibition 6.9 pIC50 - 2
⤷ pIC50 6.9 (IC50 1.2x10-7 M) [2]
Description: Biochemical enzyme inhibition assay.
fibroblast growth factor receptor 3 Hs Inhibitor Inhibition 6.6 pIC50 - 2
⤷ pIC50 6.6 (IC50 2.8x10-7 M) [2]
Description: Biochemical enzyme inhibition assay.